C -reactive protein (CRP), a pentameric molecule, is the most widely studied inflammatory marker. 1 Elevated levels of serum CRP have been associated with increased risks of cancer, 2 type 2 diabetes mellitus, 3 hypertension, 4 coronary heart disease, 5 stroke, 6 bipolar disorder, 7 and overall mortality. 8 However, its causal contribution to the pathophysiology of chronic diseases remains controversial. 9-12 Serum levels of CRP are regulated by both genetic and environmental factors. 11, 13 Its heritability has been reported to range from 10% to 65%, 14-17 and genome-wide association studies (GWASs) have successfully identified several genetic variants associated with CRP levels. 12,18 A recent meta-analysis of 25 GWAS studies, including >80 000 subjects, identified 18 CRP genetic variants at genome-wide significance. 19
Therefore, after a successful GWAS study, it is essential to perform additional post-GWAS analyses to translate the GWAS findings represented by index SNPs into biological knowledge. 21 For example, we previously demonstrated that serum protein levels are regulated by ribosomal functioning, proteasomal degradation, and immune-response signaling pathways, leading to a better functional understanding of the GWAS findings for serum protein levels. 22 However, an in-depth post-GWAS analysis for CRP variants has not yet been performed, 19 which means that CRP GWAS findings have been insufficiently translated into biological function. Consequently, the gain in knowledge on underlying mechanisms controlling CRP level has been limited. Given the clinical relevance of CRP as an established biomarker for many complex chronic disorders, an extended post-GWAS analysis of CRP variants may unravel new mechanisms, which will improve our understanding of the metabolism of CRP and its relevance to disease pathology.
Here we applied a bioinformatics-based approach to uncover the functional characteristics of the 18 CRP-associated variants. 19 We first performed an in silico sequencing analysis using 1000 Genomes Project data 23 to identify nearby nonsynonymous coding variants. Second, we performed an expression quantitative trait loci (eQTL) analysis using a large data set of blood expression probes to find regulatory variants. Third, we integrated the findings of the abovementioned phases by performing a functional network analysis to unravel the underlying biological processes.
Methods
We followed a bioinformatics-based approach, including 3 distinct phases, each consisting of multiple steps as described later (Figure 1 ).
Phase I: In Silico Sequencing

Identifying Linked Variants
First, we converted the chromosome positions of the GWAS SNPs (gSNPs) from the National Center for Biotechnology Information Build 36 (Human Genome 18) to National Center for Biotechnology Information Build 37 (Human Genome 19) using the LiftOver tool from the University of California Santa Cruz (UCSC) Genome Project. 24 Then, we targeted regions of 1 Mb at either side of each gSNP, resulting in a mini-genome of 36 Mb. The appropriate Variant Call Format 25 file for each 2 Mb region was downloaded from the 1000 Genomes Project ftp server using the Tabix software package. 26 We used the data from the 1000 Genomes Project Full Phase 1, November 2010 release (using August 2010 alignments), including only the 283 subjects of European ancestry. 23 Subsequently, for each Variant Call Format file, the r 2 between the gSNP and all other biallelic SNPs residing within the corresponding 2 Mb area was calculated as a metric of linkage disequilibrium (LD) using VCFtools. 25 Only those SNPs in moderate to high (r 2 >0.50) LD with the corresponding gSNP were used in the next step of the analysis (Figure 1 ).
Identifying Linked Nonsynonymous SNPs
All these SNPs in LD with any of the gSNPs were annotated by ANNOVAR software 27 and then filtered in a stepwise manner. First, the SNPs were annotated to distinguish exonic variants from other variant types (intronic, intergenic, etc.). Nonexonic variants were excluded from further analyses. The remaining SNPs were annotated again to distinguish synonymous from nonsynonymous exonic SNPs, and synonymous SNPs were excluded. As a further step, the nonsynonymous SNPs (nsSNPs) were then characterized for their damaging effect on the corresponding protein using Sorting Intolerant From Tolerant (SIFT) 28 and Polymorphism Phenotyping (PolyPhen) 29 prediction scores. Their scores were obtained from Ensembl release 71 (accessed June 8, 2013). 30 Whenever multiple scores were available for a single nsSNP, we selected the most damaging prediction scores as the smallest SIFT and the largest PolyPhen scores. These scores are just provided as Data Supplement about linked variants and hence, were not used in the downstream analyses.
In Silico Pleiotropy Analysis
To extend our knowledge of the possible function of the 18 CRPassociated loci, we sought to identify any trait or outcome associated with these 18 loci. Thus, for all gSNPs, as well as all SNPs in LD (r 2 >0.80) with any of the gSNPs, we checked for genome-wide significant (P<5×10 −8 ) pleiotropic effects on other complex traits or diseases identified in previous GWAS studies as listed in the National Human Genome Research Institute GWAS Catalog (Catalog of Published Genome-Wide Association Studies) 31 using ANNOVAR software (accessed June 13, 2013). 27 However, as shown in Figure 1 , the results of this step were not used in the downstream analyses, but were indeed used in the final interpretation of the results.
Phase II: eQTL Analysis
The data set of genome-wide expression probes and gene expression measurements have been described in more detail elsewhere. 32, 33 
Subjects
The 2 parent projects that supplied data for the eQTL analysis are large-scale longitudinal studies: the Netherlands Study of Depression and Anxiety 34 and the Netherlands Twin Registry. 35 The Netherlands Study of Depression and Anxiety and the Netherlands Twin Registry studies were approved by the Central Ethics Committee on Research Involving Human Subjects of the VU University Medical Center, Amsterdam, and all subjects provided written informed consent. The sample used for eQTL analysis after quality control consisted of 5071 subjects, 3109 the Netherlands Twin Registry (from 1571 families: 614 dizygotic twin pairs, 1 monozygotic triplet, 668 monozygotic twin pairs, 394 siblings, and 148 unrelated subjects), and 1962 the Netherlands Study of Depression and Anxiety participants. The age of the participants ranged from 17 to 88 years (mean 38, SD 13), and 65% of the sample was female. 32
Blood Sampling, RNA Extraction, and Measurements
Venous blood samples were drawn in the morning after an overnight fast. Heparinized whole blood samples were transferred within 20 minutes of sampling into PAXgene Blood RNA tubes (Qiagen) and stored at −20°C. Gene expression assays were conducted at the Rutgers University Cell and DNA Repository (http://www.rucdr. org). Samples were hybridized to Affymetrix U219 arrays containing 530 467 probes summarized in 49 293 probesets. All probes are 25 bases in length and designed to be perfect match complements to a designated transcript. Array hybridization, washing, staining, and scanning were performed in an Affymetrix GeneTitan System per the manufacturer's protocol. Gene expression data were required to pass standard Affymetrix quality control metrics (Affymetrix expression console) before further analysis. Probes that did not map uniquely to Human Genome 19 or that contained a polymorphic SNP (dbSNP137 common with minor allele frequency >0.01) were removed for downstream analysis, resulting in 423 201 probes, summarized in 44 241 probesets, targeting 18 238 unique genes. Probeset expression values were obtained using robust multiarray average normalization implemented in Affymetrix Power Tools (APT, v 1.12.0). Samples with low average correlation with other samples and samples with incorrect sex-chromosome expression were removed. 32
Genotype Data
DNA extraction has been described earlier. 36 Genotyping was done on multiple chip platforms for several partly overlapping subsets of participants. The following platforms were used: Affymetrix Perlegen 5.0, Illumina 370, Illumina 660, Illumina Omni Express 1 mol/L, and Affymetrix 6.0. After array-specific data analysis, genotype calls were made with the platform-specific software (Genotyper, Beadstudio). The extensive genotyping quality control steps and 1000 Genomes imputation procedures are described in the Data Supplement Text S1. Genotypes were coded into dosage format and filtered at minor allele frequency >0.01 and imputation quality of R 2 >0.30 for eQTL analysis.
eQTL Analysis
Inverse quantile normal transformation was applied to the individual probeset data to obtain normal distributions. The transformed probeset data were then residualized with respect to the covariates sex, age, body mass index, smoking status, several technical covariates, and 3 principal components (PCs) from the genotype data. Genotype PCs were constructed using pruned GWAS data after removing ethnic outliers as described earlier. 37 The residualized probeset data were subjected to a principal component analysis to remove the first 50 PCs to adjust the gene expression levels for nongenetic variation, as proposed by Fehrmann et al. They have shown that removing expression PCs drastically increases the number of eQTLs. 38 We observe the same phenomenon in our data. Removing expression PCs has become a standard procedure in many eQTL studies. 33, 39 Probesets at <1 Mb distance from the gSNPs were selected for eQTL analysis as follows: for each probeset-gSNP combination at maximally 1 Mb distance, a linear mixed model was fitted with expression level as dependent variable, genotype as fixed effect, and family ID and zygosity as random effects to account for family and twin relations. 40 Mixed models and resulting P values were computed using the function lmer from the lme4 R package (http://CRAN.R-project.org/package=lme4). To correct for multiple testing, false discovery rate (FDR) was computed using all P values from each probeset-gSNP combination at maximally 1 Mb distance using the function p.adjust from the stats R package, and any signal with FDR<0.01 was considered significant. The appropriate gene names of those significantly associated expression probes were then used in the next step as a set of prioritized biological candidate genes ( Figure 1 ).
As a further step, for each locus with significant eQTL signal of FDR<0.01, we also identified the most significantly associated eQTL SNP (eSNP) for the corresponding transcript. We then performed conditional analyses to see if the gSNP is independently associated with the expression level. For conditional eQTL analysis, the transformed probeset data were residualized with respect to the corresponding eSNP before applying the mixed model. These eSNPs were not used in the downstream analysis ( Figure 1 ).
Phase III: Network Analysis
Functional Interaction Network
To construct a functional association interaction network, we applied the GeneMANIA algorithm together with its large set of accompanying functional association data on coexpression, physical interaction, genetic interaction, shared protein domains, colocalization, and predicted association networks. This data set comprises 286 extended association networks. 41 We combined 4 biologically prioritized candidate gene sets into a single query gene set, which was used as input for the interaction network analysis: (1) closest genes to the gSNPs, (2) closest genes to the nsSNPs in high LD (r 2 >0.50) with the corresponding gSNP, (3) closest genes to other types of SNPs in very high LD (r 2 >0.80) with the corresponding gSNP, and (4) expression probe gene names significantly (FDR<0.01) associated with gSNPs based on the eQTL analysis ( Figure 1 ). We used different LD thresholds for nsSNPs than other types of SNPs as nsSNPs are more likely to be functionally important and also are more likely to reside within a lower frequency spectrum. Consequently, nsSNPs may be in modest LD with common gSNPs. Therefore, we used a more lenient LD threshold for nsSNPs (r 2 >0.50) to ensure not to miss potentially functional variants with modest frequency and a standard LD threshold of r 2 >0.80 for other types of SNPs.
Next, we constructed a weighted composite functional association network using the Cytoscape software platform, 42 extended by the GeneMANIA plugin. 43 We selected all available networks option with a 100-gene output (accessed July 15, 2013).
Functional Enrichment Analysis
All the genes in the composite network, either from the query or the resulting gene sets, were then used for functional enrichment analysis against Gene Ontology terms (GO terms) to identify the most relevant GO terms using the same plugin. 43 Each GO annotation has an evidence code indicating the type of experimental or computational support for that association, for example, inferred from reviewed computational analysis (RCA) or inferred from electronic annotation (IEA). The first one (RCA) points to those predictions based on computational analyses of experimental data sets like protein-protein interaction or expression data. The latter (IEA) points to computationally assigned evidence codes, which have not been reviewed by a curator to verify their accuracy (http://www.geneontology.org/GO.evidence.shtml). 44 IEA is the least reliable, but the most prevalent evidence code, that is, about 47% of all of the human GO annotations are based on IEA codes (accessed July 26, 2013). As both RCA and IEA annotations are solely based on computational predictions, the functional enrichment analysis was only performed against GO term annotations with non-IEA and non-RCA evidence codes to avoid circularity. 44 We considered any GO term with FDR <0.01 as significantly and those GO terms with FDR between 0.01 and 0.1 as suggestively enriched. We then used the RamiGO R package 45 for the visualization of significant GO terms within the appropriate GO tree.
Results
Here, we followed a bioinformatics-based approach as summarized in Figure 1 . We included the 18 SNPs that showed genome-wide significant association with CRP in the study by Dehghan et al 19 (Table 1 ).
Phase I: In Silico Sequencing
In this phase, we aimed to explore thoroughly the genomic area around the 18 gSNPs to identify nearby nsSNPs as potentially functional variants. We used 1000 Genomes Project data as the most detailed catalogue of human genetic variation. 23 The mini-genome of 36 Mb contains 167 003 SNPs. Of these, 3801 SNPs are in LD with the nearby gSNP at r 2 >0.10, of which only 48 are exonic, including 25 nsSNPs ( Table I in the  Data Supplement) . Of the nsSNPs, 9 map to the same gene and 16 map to other genes than the gSNPs. Please note that Tables I-III in the Data Supplement provide a thorough description of the vicinity of gSNPs by applying a liberal cutoff of r 2 >0.1.
These results are considered as complementary information. However, only 7 of the nsSNPs are in moderate to high LD (r 2 >0.5) with the gSNPs and were used in the downstream analyses ( Figure 1 ). The nsSNPs were then characterized for their deleterious effect on the corresponding protein function using 2 different tools, SIFT 28 and PolyPhen. 29 Interestingly, 8, 6, 4, and 10 of the nsSNPs are considered as damaging according to SIFT alone, PolyPhen alone, both SIFT and PolyPhen, or any of the 2 prediction scores, respectively (Figure 2 drawn by Circos 46 ; Tables I and II in the Data Supplement).
In silico pleiotropy analysis of all gSNPs, as well as all SNPs that are in LD with their nearby gSNP, identified several genome-wide significantly (P<5×10 −8 ) associated traits or diseases other than CRP that had already been reported in previous GWAS studies as listed in the GWAS catalog. 31 By considering all gSNPs and only their highly linked variants (r 2 >0.80), 10 loci had effects on other traits, whereas 8 loci, including the CRP locus itself, did not show any pleiotropic effect. The locus harboring GCKR was the most pleiotropic region, having reported GWAS associations with a variety of metabolic-related traits. Most of the identified traits are metabolic-related traits, particularly lipid-and lipoprotein-related traits, for example, cholesterol, high-density lipoprotein, lowdensity lipoprotein, and triglyceride levels ( Figure 3 ; Table III in the Data Supplement).
Phase II: eQTL Analysis
In this phase, we aimed to perform an eQTL analysis to determine whether the gSNPs affect CRP levels through regulating gene expression levels. Here we used a large data set of genome-wide expression probes in peripheral blood consisting of 5071 subjects. The eQTL analysis identified 23 expression probes that were significantly associated with 8 gSNPs at FDR<0.01. The 23 expression probes belong to 15 genes, of which 4 are the same genes and 11 are different genes from those mapping to the corresponding gSNPs. Those expression probe gene names were then used in the next step as a set of prioritized biological candidate genes (Figure 1) .
Additionally, we identified the 23 SNPs that were most significantly associated with the corresponding expression probes (eSNPs; Figure 4 ; Table IV in the Data Supplement). eQTL analysis of the gSNPs conditional on the corresponding eSNPs revealed that for the majority of expression probes, the corresponding gSNP is not independently associated with expression levels, that is, the observed effect of gSNPs on expression probes are mostly explained by the eSNPs (Table  IV in the Data Supplement).
Phase III: Network Analysis
In this phase, we generated a list of biologically prioritized candidate genes based on the findings of phases I and II as input for the construction of a functional interaction network as detailed in the methods section. Four sets of query genes were combined to create the final input list of prioritized genes for the functional interaction network analysis (Figure 1 ). After removing duplicate entries, the combined query gene set contained 40 genes. Two genes (LOC157273 and PPIEL) could not be found in any of the available interaction resources, resulting in a final list of 38 The SNPs are ordered according to the significance of their association with CRP in the meta-GWAS article. Alleles indicates ensembl reference/alternative alleles; Chr, chromosome; CRP, C-reactive protein; gSNP, GWAS SNP; GWAS, genome-wide association study; SNP, single nucleotide polymorphism; position, chromosome position build 37.
genes ( Table 2 ). The final composite association network contained those 38 query genes, as well as the output gene set, that is, the 100 genes connected to the query gene set. Altogether these were connected with 2225 associations, also known as edges ( Figure I and Table V in the Data Supplement). All the genes in the composite network were then used for functional enrichment analysis against GO terms, 47 which revealed 93 significantly (FDR<0.01) and 79 suggestively (0.1<FDR<0.01) enriched terms (Table VI in the Data Supplement). The majority of enriched terms The 3 innermost rings show complex traits or diseases other than CRP, identified in previous GWAS studies to be genome-wide significantly associated with any of the gSNPs or their highly linked variants (r 2 >0.80); Ala/Gln indicates alanine/glutamine; Cognit-decline, cognitive decline; CRP, C-reactive protein; eGFRcrea, estimated glomerular filtration rate by serum creatinine; Esophag-cancer, esophageal cancer; GGT, gamma gluatamyl transferase; gSNP, GWAS SNPs; GWAS, genome-wide association study; HDL, high-density lipoprotein; HDLC-TG, HDL cholesterol-triglycerides; HDLC-WC, HDL cholesterol-waist circumference; Hyper-TG, hypertriglyceridemia; LDL, low-density lipoprotein; Lp-PLA2, lipoprotein-associated phospholipase A2; SHBG, sex hormone-binding globulin; sIL-6R, soluble interleukin-6 receptor; SNP, single nucleotide polymorphism; TG-BP, triglycerides-blood pressure; and WC-TG, waist circumference-triglycerides; for full trait or disease names, please see Table III in the  Data Supplement. can be broadly categorized into 2 major groups: (1) terms related to immunologic processes, cytokines, and especially interferons and (2) terms related to lipids and lipoprotein metabolism.
Thirty-three of the 93 significantly enriched terms belong to the first category, of which 7 have an FDR<5×10 -15 : cytokinemediated signaling pathway (GO:0019221, FDR=9.47×10 -37 ), type I interferon-mediated signaling pathway (GO:0060337, FDR=1.05×10 -34 ), cellular response to type I interferon (GO:0071357, FDR=1.05×10 -34 ), response to type I interferon (GO:0034340, FDR=1.22×10 -34 ), interferon-γ-mediated signaling pathway (GO:0060333, FDR=5.78×10 -16 ), response to interferon-γ (GO:0034341, FDR=5.78×10 -16 ), cellular response to interferon-γ (GO:0071346, FDR=1.69×10 -15 ). Figure 5 visualizes these 7 terms within their corresponding GO tree. Ten out of 33 significantly enriched terms of this first category are specifically related to interferons (Table VI in the Data Supplement). Forty-three of 93 significantly enriched terms belong to the second category, that is, they are all related to the metabolism of fatty acids (eg, GO:0042304: regulation of fatty acid biosynthetic process, FDR=1.01×10 −4 ), triglycerides (eg, GO:0070328: triglyceride homeostasis, FDR=7.93×10 −5 ), cholesterol (eg, GO:0042632: cholesterol homeostasis, FDR=2.71×10 −4 ), and especially lipoproteins (eg, GO:0034361: very-low-density lipoprotein particle, FDR=3.45×10 −5 ; Table VI in the Data Supplement).
Discussion
In the present study, we performed a post-GWAS analysis of 18 genome-wide significantly associated CRP SNPs. This strategy yielded new information on biological processes involved in CRP metabolism.
Here we shed light on the genomic context of the vicinity of gSNPs in 2 steps. We first investigated the nearby genomic region to identify all linked variants, with emphasis on nsSNPs as potentially functional variants. A strength of this approach is the use of r 2 as a metric of LD rather than predefined physical distance. Although nsSNPs have a high likelihood to be functional, they may constitute only a small fraction of the mechanisms involved. Therefore, we included all SNP types into the analyses. In the second step, that is, the eQTL analysis, we identified any nearby gene whose expression level is associated with its corresponding gSNP. Here we used one of the largest single data sets of genome-wide expression probes in peripheral blood currently available worldwide of >5000 samples, which was analyzed by a stringent statistical approach. The 2 steps identified several relevant genes that were jointly used as the input to the next step, that is, the functional network analysis. The strength of this approach is including the genes from the eQTL analysis in the functional network analysis, as we think these genes are at least as important as those genes to which gSNPs or their linked variants map. This approach has added value to stand-alone eQTL results as they are translated to biological insights in a broader context through integration to other data domains.
In the next step, we constructed a functional association interaction network followed by functional enrichment analysis against GO terms. Such an interaction network is considered to represent cofunctionality of the connected genes. 41 The large data set of functional association data that is used contains not only coexpression data, but also physical interaction, genetic interaction, shared protein domains, colocalization, and predicted association networks. As a result, the constructed interaction network is a composite based on these different data sources. 41 As described in the methods section, the functional enrichment analysis is performed against GO terms after excluding those annotations with computer-generated inferred from RCA and IEA evidence codes. Thus, about half of the GO annotations are disregarded to avoid circularity and to obtain more robust results (http://www.geneontology. org/GO.evidence.shtml). 44 Our post-GWAS analysis of CRP GWAS SNPs eventually yielded a range of enriched biological processes after several intermediate steps. Some processes like acute-phase response or acute inflammatory response with significant FDR values are expected and appropriate terms for CRP providing confidence in our results. Interestingly, about one third of the significantly enriched terms were related to immunologic processes, cytokines, and interferons. Even more interesting, 10 of the significantly enriched terms, including 6 of the top most significant ones, are those pointing to the biology of interferons. In particular, type I interferon associated biological processes are highlighted with 3 significant enriched terms with FDR<1×10 −30 .
The link between interferons and CRP has not been well established, probably because the measurement of interferons is complicated by their short half-lives. Although few studies have addressed the direct link between CRP and interferons and although this link has not been appreciated as a potential mechanism underlying the biology of CRP, our finding is in fact amply supported by those few in vitro and clinical observations. An in vitro observation by Enocsson et al showed that interferon-α, the main representative of the type I interferon family, inhibits CRP secretion in a dose-dependent fashion mediated by the type I interferon receptor. 48 Furthermore, although CRP levels are highly associated with most inflammatory states, as CRP level is a well-known metric for the detection and evaluation of many inflammatory diseases, 10 elevated CRP levels correlate poorly with those inflammatory conditions that are characterized by high levels of interferon-α, such as systemic lupus and viral infections. [49] [50] [51] [52] [53] [54] This observation is in line with the abovementioned in vitro observation that increased levels of interferon-α suppress CRP levels. 48 Likewise, there are yet unexplained phenomena in lupus patients as there is a 10-to 50-fold increased risk of myocardial infarction, 55, 56 whereas there is no association between cardiovascular disease and CRP levels in these patients. 53 This lack of an association is unexpected because CRP is an established risk factor for coronary heart disease. 5, 6 Moreover, in lupus patients, lack of correlation between interleukin-6, the main stimulant of CRP secretion, and CRP has been reported. 57 These related observations may be explained by the fact that lupus patients are known to have a high level of interferon-α and that interferon-α is an inhibitor of CRP secretion. Another line of evidence comes from infectious diseases. In viral infections, in contrast to bacterial infections, there is generally a mild, poorly correlated increase of CRP level, making CRP a widely used diagnostic tool in distinguishing viral from bacterial infections. 54 This can be explained by the notion that patients with viral infections have high levels of interferon-α 49 and by an inverse relation between interferon-α and CRP levels. 48 Finally, although the analysis had started with CRP gSNPs, it interestingly returned 4 significantly enriched terms The query gene set includes the following: (i) closest genes to the 18 gSNPs, (ii) closest genes to the nsSNPs in high LD (r 2 >0.50) with the corresponding gSNP, (iii) closest genes to other types of SNPs in very high LD (r 2 >0.80) with the corresponding gSNP, and (iv) expression probe gene names significantly associated with gSNPs (FDR<0.01) based on the eQTL analysis. The combined query gene set contained 40 genes, of which, 2 genes, LOC157273 and PPIEL, could not be found in any of the interaction resources. The order of genes follows the order of gSNPs in Table 1 . eQTL indicates expression quantitative trait loci; FDR, false discovery rate; GWAS, genome-wide association study; LD, linkage disequilibrium; gSNP, GWAS SNPs; nsSNP, nonsynonymous SNPs; and SNP, single nucleotide polymorphism. specifically related to defense responses to viruses ( Table VI in the Data Supplement). Considering the blunted response of CRP levels to viral infections, 54 this unexpected finding once again suggests an important role of interferon-α in CRP metabolism.
The in silico pleiotropy analysis revealed several pleiotropic effects between CRP gSNPs and other metabolic traits, particularly lipid-and lipoprotein-related traits. These results show strong concordance with those from our functional network analysis, as about half of the significantly enriched GO terms point to biological processes related to lipids and lipoproteins metabolism. These findings are also fully in line with existing knowledge of overlap between the biology of CRP and lipids with metabolism of both CRP and lipids related to the liver. Further, CRP levels are significantly associated with weight, waist-circumference, body mass index, cholesterol, triglycerides, low-density lipoprotein (weakly) and negatively associated with high-density lipoprotein concentrations. 6, [58] [59] [60] [61] Both CRP and lipids are well-known risk factors for coronary heart disease. 61 Thus, our results show extensive genetic overlap between CRP and lipid metabolism, although the exact mechanisms underlying these significant associations remain to be elucidated.
In early 2010, Dickson et al suggested that observed GWAS associations between a common SNP and trait of interest can be explained by multiple rare variants at the locus in LD with that SNP, so-called synthetic associations. 62 However, there are several lines of evidence indicating that GWAS associations are rarely caused by synthetic associations with rare variants. [63] [64] [65] Later on, Visscher and colleagues state that instead the combined evidence supports a highly polygenic model of disease susceptibility which is built on causal variants across the entire range of the allele-frequencies. 66 Hence, our approach of including all gSNPs, as well as their linked SNPs and eQTL results, is more consistent with the polygenic model than with the synthetic association model.
Despite using one of the largest single data sets of genomewide expression probes for eQTL analysis, it contained only blood expression probes. This limitation may have affected the list of associated genes. A similar approach but using a large data set of tissue-specific expression data, particularly liver cells of healthy individuals, may better reveal the associated gene expressions. However, to the best of our knowledge, such a homogenous large data set of liver cells from healthy individuals does not exist yet. Furthermore, if there is cryptic relatedness among our subjects, it is possible that our eQTL results might be slightly biased. However, our population is relatively outbred and known relationships among subjects were taken into account in the analysis. Under these circumstances, Voight and Pritchard suggest that the bias is expected to be negligible. 67 Our functional enrichment analysis was done using GO terms; one may suggests a more extended approach by including other annotation sources like KEGG and Reactome pathways. However, as these resources only contain a limited number of pathways, it is unlikely this would have affected our main conclusions.
Finally, the results of this in silico study need to be followed up by further in vitro, in vivo, and epidemiological studies. The association of interferon-α with coronary heart disease and other CRP-associated traits or diseases, as well as the association of CRP gSNPs or CRP genetic risk scores with clinical conditions like systemic lupus, are yet to be investigated. These results also highlight the need and potential for a GWAS on serum levels of interferon-α. Finally, although those CRP gSNPs are based on a large meta-GWAS, including >80 000 subjects, the explained variance in CRP level by all those 18 gSNPs is only around 5%. 19 To further unravel the underlying genetic mechanisms controlling CRP levels, a larger meta-GWAS on CRP is needed to find additional common variants, whereas other approaches, such as meta-analyses of exome chip data, will be needed to find variants of lower frequency affecting serum levels of CRP.
In summary, in this in silico study, we followed a bioinformatics-based approach aiming to translate CRP GWAS signals into biological insights. Our post-GWAS analysis of CRP GWAS SNPs reemphasizes the previously known overlap between the biology of CRP and lipids. Additionally, it suggests an important role for interferons in the metabolism of CRP.
Accession numbers: Gene expression and genotype data used for this study will be available at dbGaP, accession number phs000486.v1.p1 (http://www.ncbi.nlm.nih.gov/projects/ gap/cgi-bin/study.cgi?study_id=phs000486.v1.p1). 
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